Literature DB >> 19378439

A combined abnormality in heart rate variation and QT corrected interval is a strong predictor of cardiovascular death in type 1 diabetes.

J A Lykke1, L Tarnow, H H Parving, J Hilsted.   

Abstract

OBJECTIVE: Long-term diabetes is associated with excess morbidity and mortality, and cardiovascular autonomic neuropathy and QTc interval abnormalities are both predictive of early cardiovascular death in diabetes. We aimed to investigate the effect of these risk factors in a large cohort of type 1 diabetic patients followed prospectively for 10 years.
MATERIAL AND METHODS: Three-hundred-and-ninety-one type 1 diabetic mellitus patients (240 M and 151 F, age 41.8 years +/- 9.9 (mean +/-SD), duration of DM 27.3 years +/- 8.2) were followed in an outpatient setting.
RESULTS: Patients with decreased heart rate variability had an excess overall mortality that diminished after adjusting for conventional cardiovascular risk factors; hazard ratio 2.5 (0.9-6.8; p = 0.071) compared to patients with normal heart rate variability. Likewise, prolonged QTc interval was associated with premature death with an adjusted hazard ratio of 2.3 (1.3-4.0; p = 0.005). In a combined analysis, patients with abnormal values for heart rate variability and QTc had a poorer prognosis compared to patients with normal test values for both parameters (adjusted hazard ratio 6.7 (1.8-25; p = 0.005)). Of the 34 patients with both test values abnormal, 15 died and 14 of these from cardiovascular causes.
CONCLUSIONS: We conclude that combined abnormality in heart rate variability and QTc is a strong predictor of mortality in type 1 diabetes independently of conventional risk factors. These results have implications for future screening and treatment programmes for cardiovascular disease in type 1 diabetes.

Entities:  

Mesh:

Year:  2008        PMID: 19378439     DOI: 10.1080/00365510802018330

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  19 in total

1.  Web-enabled and improved software tools and data are needed to measure nutrient intakes and physical activity for personalized health research.

Authors:  Phyllis J Stumbo; Rick Weiss; John W Newman; Jean A Pennington; Katherine L Tucker; Paddy L Wiesenfeld; Anne-Kathrin Illner; David M Klurfeld; Jim Kaput
Journal:  J Nutr       Date:  2010-10-27       Impact factor: 4.798

Review 2.  What do we know and we do not know about cardiovascular autonomic neuropathy in diabetes.

Authors:  Rodica Pop-Busui
Journal:  J Cardiovasc Transl Res       Date:  2012-05-30       Impact factor: 4.132

Review 3.  Drug-induced QT interval shortening: potential harbinger of proarrhythmia and regulatory perspectives.

Authors:  Rashmi R Shah
Journal:  Br J Pharmacol       Date:  2009-06-25       Impact factor: 8.739

4.  Autonomic control during acute hypoglycemia in type 1 diabetes mellitus.

Authors:  Jacqueline K Limberg; Kathryn E Farni; Jennifer L Taylor; Simmi Dube; Ananda Basu; Rita Basu; Erica A Wehrwein; Michael J Joyner
Journal:  Clin Auton Res       Date:  2014-09-27       Impact factor: 4.435

Review 5.  Diabetes and cardiac autonomic neuropathy: Clinical manifestations, cardiovascular consequences, diagnosis and treatment.

Authors:  Akif Serhat Balcıoğlu; Haldun Müderrisoğlu
Journal:  World J Diabetes       Date:  2015-02-15

Review 6.  When are type 1 diabetic patients at risk for cardiovascular disease?

Authors:  Trevor J Orchard; Tina Costacou
Journal:  Curr Diab Rep       Date:  2010-02       Impact factor: 4.810

7.  Cardiovascular Autonomic Neuropathy and Cardiovascular Outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.

Authors:  Rodica Pop-Busui; Barbara H Braffett; Bernie Zinman; Catherine Martin; Neil H White; William H Herman; Saul Genuth; Rose Gubitosi-Klug
Journal:  Diabetes Care       Date:  2016-11-01       Impact factor: 19.112

Review 8.  Cardiac autonomic neuropathy in diabetes: a clinical perspective.

Authors:  Rodica Pop-Busui
Journal:  Diabetes Care       Date:  2010-02       Impact factor: 19.112

9.  Neuropathy: the crystal ball for cardiovascular disease?

Authors:  Aaron I Vinik; Raelene E Maser; Dan Ziegler
Journal:  Diabetes Care       Date:  2010-07       Impact factor: 17.152

10.  Endotoxin depresses heart rate variability in mice: cytokine and steroid effects.

Authors:  Karen D Fairchild; Jeffrey J Saucerman; Laura L Raynor; Joseph A Sivak; Yuping Xiao; Douglas E Lake; J Randall Moorman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-08-05       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.